TY - JOUR

T1 - ARIA digital anamorphosis

T2 - Digital transformation of health and care in airway diseases from research to practice

AU - Bousquet, Jean

AU - Anto, Josep M.

AU - Bachert, Claus

AU - Haahtela, Tari

AU - Zuberbier, Torsten

AU - Czarlewski, Wienczyslawa

AU - Bedbrook, Anna

AU - Bosnic-Anticevich, Sinthia

AU - Walter Canonica, G.

AU - Cardona, Victoria

AU - Costa, Elisio

AU - Cruz, Alvaro A.

AU - Erhola, Marina

AU - Fokkens, Wytske J.

AU - Fonseca, Joao A.

AU - Illario, Maddalena

AU - Ivancevich, Juan Carlos

AU - Jutel, Marek

AU - Klimek, Ludger

AU - Kuna, Piotr

AU - Kvedariene, Violeta

AU - Le, L. T.T.

AU - Larenas-Linnemann, Désirée E.

AU - Laune, Daniel

AU - Lourenço, Olga M.

AU - Melén, Erik

AU - Mullol, Joaquim

AU - Niedoszytko, Marek

AU - Odemyr, Mikaëla

AU - Okamoto, Yoshitaka

AU - Papadopoulos, Nikos G.

AU - Patella, Vincenzo

AU - Pfaar, Oliver

AU - Pham-Thi, Nhân

AU - Rolland, Christine

AU - Samolinski, Boleslaw

AU - Sheikh, Aziz

AU - Sofiev, Mikhail

AU - Suppli Ulrik, Charlotte

AU - Todo-Bom, Ana

AU - Tomazic, Peter Valentin

AU - Toppila-Salmi, Sanna

AU - Tsiligianni, Ioanna

AU - Valiulis, Arunas

AU - Valovirta, Erkka

AU - Ventura, Maria Teresa

AU - Walker, Samantha

AU - Williams, Sian

AU - Yorgancioglu, Arzu

AU - Agache, Ioana

AU - Akdis, Cezmi A.

AU - Almeida, Rute

AU - Ansotegui, Ignacio J.

AU - Annesi-Maesano, Isabella

AU - Arnavielhe, Sylvie

AU - Basagaña, Xavier

AU - D. Bateman, Eric

AU - Bédard, Annabelle

AU - Bedolla-Barajas, Martin

AU - Becker, Sven

AU - Bennoor, Kazi S.

AU - Benveniste, Samuel

AU - Bergmann, Karl C.

AU - Bewick, Michael

AU - Bialek, Slawomir

AU - E. Billo, Nils

AU - Bindslev-Jensen, Carsten

AU - Bjermer, Leif

AU - Blain, Hubert

AU - Bonini, Matteo

AU - Bonniaud, Philippe

AU - Bosse, Isabelle

AU - Bouchard, Jacques

AU - Boulet, Louis Philippe

AU - Bourret, Rodolphe

AU - Boussery, Koen

AU - Braido, Fluvio

AU - Briedis, Vitalis

AU - Briggs, Andrew

AU - Brightling, Christopher E.

AU - Brozek, Jan

AU - Brusselle, Guy

AU - Brussino, Luisa

AU - Buhl, Roland

AU - Buonaiuto, Roland

AU - Calderon, Moises A.

AU - Camargos, Paulo

AU - Camuzat, Thierry

AU - Caraballo, Luis

AU - Carriazo, Ana Maria

AU - Carr, Warner

AU - Cartier, Christine

AU - Casale, Thomas

AU - Cecchi, Lorenzo

AU - Cepeda Sarabia, Alfonso M.

AU - H. Chavannes, Niels

AU - Chkhartishvili, Ekaterine

AU - Chu, Derek K.

AU - Cingi, Cemal

AU - Correia de Sousa, Jaime

AU - Costa, David J.

AU - Courbis, Anne Lise

AU - Custovic, Adnan

AU - Cvetkosvki, Biljana

AU - D'Amato, Gennaro

AU - da Silva, Jane

AU - Dantas, Carina

AU - Dokic, Dejan

AU - Dauvilliers, Yves

AU - De Feo, Giulia

AU - De Vries, Govert

AU - Devillier, Philippe

AU - Di Capua, Stefania

AU - Dray, Gerard

AU - Dubakiene, Ruta

AU - Durham, Stephen R.

AU - Dykewicz, Marc

AU - Ebisawa, Motohiro

AU - Gaga, Mina

AU - El-Gamal, Yehia

AU - Heffler, Enrico

AU - Emuzyte, Regina

AU - Farrell, John

AU - Fauquert, Jean Luc

AU - Fiocchi, Alessandro

AU - Fink-Wagner, Antje

AU - Fontaine, Jean François

AU - Fuentes Perez, José M.

AU - Gemicioğlu, Bilun

AU - Gamkrelidze, Amiran

AU - Garcia-Aymerich, Judith

AU - Gevaert, Philippe

AU - Gomez, René Maximiliano

AU - González Diaz, Sandra

AU - Gotua, Maia

AU - Guldemond, Nick A.

AU - Guzmán, Maria Antonieta

AU - Hajjam, Jawad

AU - Huerta Villalobos, Yunuen R.

AU - Humbert, Marc

AU - Iaccarino, Guido

AU - Ierodiakonou, Despo

AU - Iinuma, Tomohisa

AU - Jassem, Ewa

AU - Joos, Guy

AU - Jung, Ki Suck

AU - Kaidashev, Igor

AU - Kalayci, Omer

AU - Kardas, Przemyslaw

AU - Keil, Thomas

AU - Khaitov, Musa

AU - Khaltaev, Nikolai

AU - Kleine-Tebbe, Jorg

AU - Kouznetsov, Rostislav

AU - Kowalski, Marek L.

AU - Kritikos, Vicky

AU - Kull, Inger

AU - La Grutta, Stefania

AU - Leonardini, Lisa

AU - Ljungberg, Henrik

AU - Lieberman, Philip

AU - Lipworth, Brian

AU - Lodrup Carlsen, Karin C.

AU - Lopes-Pereira, Catarina

AU - Loureiro, Claudia C.

AU - Louis, Renaud

AU - Mair, Alpana

AU - Mahboub, Bassam

AU - Makris, Michaël

AU - Malva, Joao

AU - Manning, Patrick

AU - Marshall, Gailen D.

AU - Masjedi, Mohamed R.

AU - Maspero, Jorge F.

AU - Carreiro-Martins, Pedro

AU - Makela, Mika

AU - Mathieu-Dupas, Eve

AU - Maurer, Marcus

AU - De Manuel Keenoy, Esteban

AU - Melo-Gomes, Elisabete

AU - Meltzer, Eli O.

AU - Menditto, Enrica

AU - Mercier, Jacques

AU - Micheli, Yann

AU - Miculinic, Neven

AU - Mihaltan, Florin

AU - Milenkovic, Branislava

AU - Mitsias, Dimitirios I.

AU - Moda, Giuliana

AU - Mogica-Martinez, Maria Dolores

AU - Mohammad, Yousser

AU - Montefort, Steve

AU - Monti, Ricardo

AU - Morais-Almeida, Mario

AU - Mösges, Ralph

AU - Münter, Lars

AU - Muraro, Antonella

AU - Murray, Ruth

AU - Naclerio, Robert

AU - Napoli, Luigi

AU - Namazova-Baranova, Leyla

AU - Neffen, Hugo

AU - Nekam, Kristoff

AU - Neou, Angelo

AU - Nordlund, Björn

AU - Novellino, Ettore

AU - Nyembue, Dieudonné

AU - O'Hehir, Robyn

AU - Ohta, Ken

AU - Okubo, Kimi

AU - Onorato, Gabrielle L.

AU - Orlando, Valentina

AU - Ouedraogo, Solange

AU - Palamarchuk, Julia

AU - Pali-Schöll, Isabella

AU - Panzner, Peter

AU - Park, Hae Sim

AU - Passalacqua, Gianni

AU - Pépin, Jean Louis

AU - Paulino, Ema

AU - Pawankar, Ruby

AU - Phillips, Jim

AU - Picard, Robert

AU - Pinnock, Hilary

AU - Plavec, Davor

AU - Popov, Todor A.

AU - Portejoie, Fabienne

AU - Price, David

AU - Prokopakis, Emmanuel P.

AU - Psarros, Fotis

AU - Pugin, Benoit

AU - Puggioni, Francesca

AU - Quinones-Delgado, Pablo

AU - Raciborski, Filip

AU - Rajabian-Söderlund, Rojin

AU - Regateiro, Frederico S.

AU - Reitsma, Sietze

AU - Rivero-Yeverino, Daniela

AU - Roberts, Graham

AU - Roche, Nicolas

AU - Rodriguez-Zagal, Erendira

AU - Rolland, Christine

AU - Roller-Wirnsberger, Regina E.

AU - Rosario, Nelson

AU - Romano, Antonino

AU - Rottem, Menachem

AU - Ryan, Dermot

AU - Salimäki, Johanna

AU - Sanchez-Borges, Mario M.

AU - Sastre, Joaquin

AU - Scadding, Glenis K.

AU - Scheire, Sophie

AU - Schmid-Grendelmeier, Peter

AU - Schünemann, Holger J.

AU - Sarquis Serpa, Faradiba

AU - Shamji, Mohamed

AU - Sisul, Juan Carlos

AU - Sofiev, Mikhail

AU - Solé, Dirceu

AU - Somekh, David

AU - Sooronbaev, Talant

AU - Sova, Milan

AU - Spertini, François

AU - Spranger, Otto

AU - Stellato, Cristiana

AU - Stelmach, Rafael

AU - Thibaudon, Michel

AU - To, Teresa

AU - Toumi, Mondher

AU - Usmani, Omar

AU - Valero, Antonio A.

AU - Valenta, Rudolph

AU - Valentin-Rostan, Marylin

AU - Pereira, Marilyn Urrutia

AU - van der Kleij, Rianne

AU - Van Eerd, Michiel

AU - Vandenplas, Olivier

AU - Vasankari, Tuula

AU - Vaz Carneiro, Antonio

AU - Vezzani, Giorgio

AU - Viart, Frédéric

AU - Viegi, Giovanni

AU - Wallace, Dana

AU - Wagenmann, Martin

AU - Wang, De Yun

AU - Waserman, Susan

AU - Wickman, Magnus

AU - Williams, Dennis M.

AU - Wong, Gary

AU - Wroczynski, Piotr

AU - Yiallouros, Panayiotis K.

AU - Yusuf, Osman M.

AU - Zar, Heather J.

AU - Zeng, Stéphane

AU - Zernotti, Mario E.

AU - Zhang, Luo

AU - Shan Zhong, Nan

AU - Zidarn, Mihaela

N1 - Funding Information: MA reports personal fees from POCI‐01‐0145‐FEDER‐029130 mINSPIRERS—mHealth to measure and improve adherence to medication in chronic obstructive respiratory diseases—generalization and evaluation of gamification, peer support and advanced image processing technologies from ERDF (European Regional Development Fund) funded by the COMPETE2020 and by National Funds through FCT (Fundação para a Ciência e a Tecnologia). EB reports personal fees from Novartis, Menarini, ALK, Sanofi Regeneron, Boehringer Ingelheim, AstraZeneca, Sanofi Genzyme, Orion, and is a member of the Science Committee and Board of the Global Initiative for Asthma (GINA). PB reports personal fees and other from Roche, Boehringer and Novartis, personal fees from AstraZeneca and TEVA, and other from Chiesi and Stallergenes. LPB reports research grants for participation to multicentre studies from AstraZeneca, Boston Scientific, GlaxoSmithKline, Hoffman La Roche, Novartis, Ono Pharma, Sanofi and Takeda, support for research projects introduced by the investigator from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck and Takeda, fee for consulting and advisory boards from Astra Zeneca, Novartis and Methapharm, nonprofit grants for production of educational materials from AstraZeneca, Boehringer‐Ingelheim, GlaxoSmithKline, Merck and Novartis, conference fees from AstraZeneca, GlaxoSmithKline, Merck and Novartis, and support for participation in conferences and meetings from Novartis and Takeda. JB reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi Aventis, Takeda, Teva, and Uriach, and other from KYomed INNOV. RB reports personal fees from AstraZeneca, Chiesi, Cipla, Sanofi and Teva, grants and personal fees from Boehringer Ingelheim, Novartis and Roche, and grants from GlaxoSmithKline, all outside the submitted work. VC reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermo Fisher and Stallergenes. JCS reports other from Boehringer Ingelheim, GSK, personal fees, nonfinancial support and other from AstraZeneca, personal fees and other from Mundipharma. AC reports personal fees from Novartis, Regeneron, Thermo Fisher Scientific, Philips and Sanofi. ME reports personal fees from DBV Technologies and Mylan. JF reports being a partner in a company developing mobile technologies for monitoring airways diseases. EH reports personal fees from AstraZeneca, Novartis, GSK, Sanofi Genzyme, Teva, Circassia and Nestlè Purina. GI is consultant for Amicus Therapeutics and received a research grant from Amicus therapeutics. PK reports personal fees from Aflofarm, Fresenius, Lek‐AM, Novartis, Polpharma and Sandoz, grants from European Union, European Commission. LK reports personal fees from Allergopharma, HAL Allergie, ALK‐Abelló, LETI Pharma, Allergy Therapeutics, Stallergenes, Quintiles, AstraZeneca, GSK, ASIT biotech and Lofarma, and grants and personal fees from MEDA/Mylan and Sanofi. DLL reports personal fees from Armstrong, Astrazeneca, Boehringer Ingelheim, Chiesi, DBV Technologies, Grunenthal, GSK, MEDA, Menarini, MSD, Novartis, Pfizer, Novartis, Sanofi, Siegfried and UCB, grants from Sanofi, Astrazeneca, Novartis, UCB, GSK, TEVA, Boehringer Ingelheim and Chiesi. RL reports grants and personal fees from GSK, from AZ and Novartis and grants from Chiesi. Dr Loureiro reports personal fees from AstraZeneca, Novartis, GSK, Sanofi, TEVA and Menarini. JM reports personal fees and nonfinancial support from Novartis, Sanofi, AstraZeneca and Immunotek. MM reports grants and personal fees from Aralez, AstraZeneca, FAES, Genentech, Novartis, MSD, Roche, Sanofi, UCB and Uriach. JM reports personal fees from ALK‐Abelló, Sanofi Genzyme & Regeneron, Menarini Group, MSD, Mitsubishi‐Tanabe, Novartis, UCB Pharma, and GENENTECH—Roche, grants and personal fees from URIACH Group, MYLAN‐MEDA Pharma. AM reports personal fees from Aimmune, DVB, Nestlè Health Institute and Nestlè Purina. BN reports other from Co‐founded AsthmaTuner, eHealth system for asthma. YO reports personal fees from Kyowa Co., Ltd, Eizai Co., Ltd, Shionogi Co., Ltd., Torii Co., Ltd., GSK and MSD, grants and personal fees from Kyorin Co., Ltd., and Tiho Co., Ltd., grants from Yakuruto Co., Ltd., and Yamada Bee Farm. NP reports personal fees from Novartis, Nutricia, HAL, MENARINI/FAES FARMA, Sanofi, Mylan/Meda, BIOMAY, AstraZeneca, GSK, MSD, ASIT BIOTECH and Boehringer Ingelheim, and grants from Gerolymatos International SA and Capricare. JLP reports grants and personal fees from Air Liquide Foundation, Agiradom, AstraZeneca, Philips and ResMed, grants from Fisher and Paykel, Mutualia and Vitalaire, personal fees from Boehringer Ingelheim, Jazz pharmaceutical, Night Balance and Sefam. DP reports personal fees, nonfinancial support and other from Revenio, grants and personal fees from GlaxoSmithKline, personal fees from Merck and Sandoz, other from Boehringer Ingelheim, Novartis, MSD and Chiesi, nonfinancial support from Menarini, nonfinancial support from Pharmas, and personal fees and nonfinancial support from Salveo. DP reports personal fees from Amgen, Mundipharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Cipla, GlaxoSmithKline, Kyorin and Thermo Fisher, grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia and Mylan, grants from Respiratory Effectiveness Group, Sanofi Genzyme, Teva and Theravance, grants from UK National Health Service, nonfinancial support from Efficacy and Evaluation Mechanism Programme, Health Technology Assessment and stock/stock options from AKL Research and Development Ltd which produces phytopharmaceuticals, and owns 74% of the social enterprise Optimum Patient Care Ltd (Australia and UK) and 74% of Observational and Pragmatic Research Institute Pte Ltd (Singapore). FP has been scientific consultant, researcher and speaker supported by the following commercial companies: Menarini, Alk‐Abello, Almirall, Allergy Therapeutics, Anallergo, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GSK, Hal Allergy, Lab. Guidotti, Lofarma, Malesci, MSD, Mundipharma, Novartis, Roche, Sanofi, Stallergenes and Valea. Dr Sastre is consultant for Thermo Fisher, Hycor, Novartis, Sanofi, Leti, Mundipharma, ALK and GSK, paid conferences from Novartis, GSK, Circassia, Sanofi, LETI and FAES FARMA, and research grants from Thermo Fisher, Mundipharma, ALK, Sanofi. GS reports personal fees from ALK, Mylan and ALK and other from Rhinology & Laryngology Research Fund, BSACI and EAACI. MS reports fees from ASIT Biotech.sa, ALK and Allergopharma. AMTB reports grants and personal fees from Novartis, Sanofi, Mundipharma, GSK (GlaxoSmithKline) and Teva Pharma, personal fees from AstraZeneca, grants from Boehringer Ingelheim, outside the submitted work. IT reports personal fees from Honoraria for educational activities, speaking engagements, advisory boards from Boehringer Ingelheim, Astra Zeneca, GSK and Novartis and grants from GSK Hellas and Elpen. MW reports personal fees from ALK‐Abello, AstraZeneca, Bencard Allergie, HAL Allergy, Leti Pharma, Meda Pharma, Novartis, Sanofi Aventis, Stallergenes and Teva. SW reports personal fees and other from CSL Behring, Shire, AstraZeneca, Teva, Meda, Merck, GSK and Novartis, personal fees from Pediapharm, Aralez, Sanofi and Stallergenes. The other authors have no conflict of interest to declare. Publisher Copyright: © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

PY - 2020

Y1 - 2020

N2 - Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.

AB - Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.

KW - ARIA

KW - asthma

KW - CARAT

KW - digital transformation of health and care

KW - MASK

KW - rhinitis

U2 - 10.1111/all.14422

DO - 10.1111/all.14422

M3 - Review

C2 - 32512619

AN - SCOPUS:85093537037

VL - 76

SP - 168

EP - 190

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 1

ER -